Preparation, Characterization, and Mechanism of Hypoglycemic Action of a Goat Casein Peptide Delivery System Involving DPP-IV Inhibition and GLP-1 Release
Foods · 05.11.2025 · 14 (21) · 3795
DOI: 10.3390/foods14213795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foods, online erschienen am 05.11.2025. Verfasst von Xiaojing Du und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center of Wheat and Corn Further Processing, Henan University of Technology, Zhengzhou 450001, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xiaojing Du, Henan Provincial Science and Technology Research and Development Program Joint Fund, Open Project Program of National Engineering Research Center of Wheat and Corn Further Processing, Henan University of Technology.
Abstract (Originalsprache)
This study aimed to formulate a carrier system to improve the oral bioaccessibility of goat casein peptides (GCAPS). Goat casein was hydrolyzed with papain and subsequently purified to obtain bioactive peptide fractions (GCAPS) with potent hypoglycemic activity. On this basis, spherical GCAPS-loaded nanocarrier systems were developed, including liposomes (GCAPS-LS) and niosomes (GCAPS-NS). Among them, GCAPS-NS exhibited higher encapsulation efficiency (94.98 ± 3.01%) and a smaller particle size (89.81 ± 8.97 nm) than GCAPS-LS. FT-IR analysis confirmed successful peptide encapsulation. Simulated gastrointestinal digestion experiments demonstrated that GCAPS-NS significantly improved GCAPS retention and DPP-IV inhibition. In vivo results from high-fat diet-induced (HFD) insulin-resistant mice demonstrated that GCAPS-NS effectively ameliorated metabolic abnormalities by including adiposity, enhancing GLP-1 levels and suppressing hsCRP expression, thereby contributing to improved glycemic homeostasis. Moreover, GCAPS-NS intervention resulted in a significant enrichment of Akkermansia and a reduced Firmicutes/Bacteroidetes ratio, suggesting its beneficial role in alleviating HFD gut dysbiosis. These findings indicated that goat casein peptides held great potential as a functional food for the management of type 2 diabetes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Engineering Research Center of Wheat and Corn Further Processing, Henan University of Technology, Zhengzhou 450001, China.
- College of Food Science and Engineering, Henan University of Technology, Zhengzhou 450001, China.
- The State Key Laboratory of Food Science & Technology, Jiangnan University, Wuxi 214122, China.
- Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, Wuxi 214122, China.
ORCID-Profile: Xiaojing Du
Förderung
- Xiaojing Du
- Henan Provincial Science and Technology Research and Development Program Joint Fund
- Open Project Program of National Engineering Research Center of Wheat and Corn Further Processing, Henan University of Technology
- Henan Provincial Natural Science Project
Zitieren
APA
Du, X., Niu, W., & Wang, H. (2025). Preparation, Characterization, and Mechanism of Hypoglycemic Action of a Goat Casein Peptide Delivery System Involving DPP-IV Inhibition and GLP-1 Release. Foods, 14(21), 3795. https://doi.org/10.3390/foods14213795
Vancouver
Du X, Niu W, Wang H. Preparation, Characterization, and Mechanism of Hypoglycemic Action of a Goat Casein Peptide Delivery System Involving DPP-IV Inhibition and GLP-1 Release. Foods. 2025;14(21):3795. doi:10.3390/foods14213795
BibTeX
@article{Du2025,
author = {Du, Xiaojing and Niu, Wenlin and Wang, Hongxin},
title = {Preparation, Characterization, and Mechanism of Hypoglycemic Action of a Goat Casein Peptide Delivery System Involving DPP-IV Inhibition and GLP-1 Release},
journal = {Foods},
year = {2025},
volume = {14},
number = {21},
pages = {3795},
doi = {10.3390/foods14213795}
}
EUVIMED